Comac Medical is pleased to announce our participation in China Trials 17, taking place on November 12–14, 2025, in Shanghai, China. Organized by PharmaDJ, this leading event gathers senior executives and experts from across China’s clinical development ecosystem to discuss trends, challenges, and opportunities shaping the country’s role in global drug development.

Representing Comac Medical at the conference will be Christian Buhlmann, Chief Commercial Officer, who will connect with industry leaders, regulators, and innovators to explore strategic partnerships and share insights into global clinical development best practices.

The China Trials 17 agenda will feature in-depth discussions on:
🔹 Regulatory and Policy Developments – Updates on China’s evolving clinical research framework and global integration.
🔹 Innovation and Collaboration – Fostering partnerships between multinational pharma, local biotech, and CROs.
🔹 Operational Excellence – Strategies for enhancing trial quality, efficiency, and patient engagement in China’s dynamic market.

With Comac Medical’s growing presence in the Asia-Pacific region, our participation highlights our commitment to advancing cross-border collaboration and supporting clinical research excellence worldwide.

Join us in Shanghai, November 12–14, to learn how Comac Medical’s integrated services and regional expertise can accelerate your development programs in China and beyond.
We look forward to connecting with you at China Trials 17!